HOUSE 2376116th CongressSubcommittee Hearings Held.

Prescription Pricing for the People Act of 2019

Last Action: 5/21/2019

Actions

2019-05-21Subcommittee Hearings Held.
2019-04-30Referred to the Subcommittee on Consumer Protection and Commerce.
2019-04-30Ordered to be Reported by Voice Vote.
2019-04-30Committee Consideration and Mark-up Session Held.
2019-04-30Referred to the Subcommittee on Health.
2019-04-29Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-29Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-29Introduced in House
2019-04-29Introduced in House

CRS Summary

As of 2019-04-29 (00)

Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.

Cosponsors (7)

JERROLD NADLER (D-NY)
Steve Cohen (D-TN)
Mark Meadows (R-NC)
Joe Neguse (D-CO)
Max Rose (D-NY)
Katie Porter (D-CA)
Mark Pocan (D-WI)

Subjects

Business ethics
Business records
Competition and antitrust
Congressional oversight
Consumer affairs
Health care costs and insurance
Health information and medical records
Inflation and prices
Prescription drugs
Retail and wholesale trades

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.